498532-32-4 Usage
Uses
Used in Pharmaceutical Industry:
Cis-cyclohexane-1,3-diamine hydrochloride is used as a key intermediate for the production of various drugs and pharmaceuticals. Its role in the synthesis of biologically active compounds makes it an essential component in the development of new medications.
Used in Organic Compounds Synthesis:
This chemical compound is utilized as a versatile building block in the synthesis of a broad spectrum of organic compounds, contributing to the advancement of chemical research and product development.
Used in Polymer Production:
Cis-cyclohexane-1,3-diamine hydrochloride is employed in the production of polymers, which are essential materials in various industries, including plastics, textiles, and coatings.
Used in Industrial Chemicals Manufacturing:
This chemical is also used in the manufacturing process of other industrial chemicals, highlighting its multifaceted utility in the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 498532-32-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,8,5,3 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 498532-32:
(8*4)+(7*9)+(6*8)+(5*5)+(4*3)+(3*2)+(2*3)+(1*2)=194
194 % 10 = 4
So 498532-32-4 is a valid CAS Registry Number.
498532-32-4Relevant academic research and scientific papers
Brown, Alan,Ellis, David,Favor, David A.,Kirkup, Tony,Klute, Wolfgang,MacKenny, Malcolm,McMurray, Gordon,Stennett, Adam
, p. 6118 - 6122 (2013)
A new series of 2-(benzyloxy)benzamides are presented that are potent functional antagonists of TRPM8 and possess improved LipE and LE compared to the original lead. They were discovered through a series of compound libraries and we present a powerful visualization method for the chemical space explored with each library. Remarkably this new series originated from the highest risk design strategy where compounds were synthesised with the least degree of similarity to the lead structure.
COMPOUNS, COMPOSITIONS AND METHODS OF USE
-
, (2018/07/29)
Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.
